Last update 27 Feb 2026

IPL-512602

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AVE 0547, AVE-0547, IPL 512602
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
Immune System DiseasesRespiratory DiseasesInfectious Diseases+ [1]
Active Indication-
Inactive Indication
AsthmaPersistent asthmaRhinitis, Allergic
Originator Organization
Orexo ABOrexo AB
Active Organization-
Inactive Organization
Inflazyme PharmaceuticalsInflazyme PharmaceuticalsSanofiSanofiOrexo ABOrexo AB
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with IPL-512602
NCT00330070
/ CompletedPhase 2
An 8 Week, Randomized, Double-Blind, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of Oral IPL512,602 to Placebo in Subjects With Moderate to Severe Persistent Asthma Inadequately Controlled on Inhaled Corticosteroids
100 Clinical Results associated with IPL-512602
Login to view more data
100 Translational Medicine associated with IPL-512602
Login to view more data
100 Patents (Medical) associated with IPL-512602
Login to view more data
100 Deals associated with IPL-512602
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Persistent asthmaPhase 2
United States
Inflazyme PharmaceuticalsInflazyme Pharmaceuticals
01 May 2006
AsthmaPhase 2-
SanofiSanofi
-
AsthmaPhase 2-
Orexo ABOrexo AB
-
Rhinitis, AllergicPreclinical
North America
--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free